BVS – bioventus inc. - class a (US:NASDAQ)
Stock Stats
News
Bioventus (BVS) is now covered by CJS Securities. They set an "outperform" rating and a $14.00 price target on the stock.
Bioventus (BVS) had its price target raised by Barrington Research from $13.00 to $14.00. They now have an "outperform" rating on the stock.
Bioventus (BVS) had its price target raised by Craig Hallum from $15.00 to $16.00. They now have a "buy" rating on the stock.
Bioventus Q4 Earnings Call Highlights [Yahoo! Finance]
Bioventus outlines $600M–$610M 2026 sales target with accelerated investment in PNS, PRP, and ultrasonics [Seeking Alpha]
Form ARS Bioventus Inc. For: Dec 31
Form DEFA14A Bioventus Inc.
Form DEF 14A Bioventus Inc. For: Dec 31
Form 4/A Bioventus Inc. For: Apr 01 Filed by: Cowdy Philip G.
Form 4/A Bioventus Inc. For: Feb 11 Filed by: Cowdy Philip G.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.